{
  "version": "HEIM-Biobank v2.0 (IHCC)",
  "generated": "2026-01-09",
  "description": "Sensitivity analysis showing how UK Biobank (UKB) dominance affects overall statistics",
  "summary": {
    "ukb_share_of_publications": 35.7,
    "ukb_is_only_strong_rated": true,
    "recommendation": "Results remain valid but should be interpreted acknowledging UKB's outsized influence"
  },
  "statistics_comparison": {
    "with_ukb": {
      "total_biobanks": 70,
      "total_publications": 38595,
      "mean_eas": 24.1,
      "median_eas": 19.7,
      "eas_std": 15.6,
      "high_category": 1,
      "moderate_category": 14,
      "low_category": 55,
      "diseases_with_coverage": 175,
      "top_eas_biobank": {
        "id": "ukb",
        "name": "UK Biobank",
        "eas": 84.6
      }
    },
    "without_ukb": {
      "total_biobanks": 69,
      "total_publications": 24810,
      "mean_eas": 23.2,
      "median_eas": 19.5,
      "eas_std": 13.9,
      "high_category": 0,
      "moderate_category": 13,
      "low_category": 56,
      "diseases_with_coverage": 178,
      "top_eas_biobank": {
        "id": "nhs",
        "name": "Nurses' Health Study",
        "eas": 55.1
      },
      "notes": [
        "No biobank achieves 'High' EAS category without UK Biobank",
        "Second-highest EAS (55.1) is 29.4 points below UK Biobank (84.6)",
        "The gap between UK Biobank and #2 exceeds the entire range of other biobanks"
      ]
    }
  },
  "publication_concentration": {
    "ukb_publications": 13785,
    "ukb_percentage": 35.7,
    "top_5_biobanks": {
      "total_publications": 25048,
      "percentage_of_total": 64.9,
      "biobanks": ["UK Biobank", "Women's Health Initiative", "Nurses' Health Study", "EPIC", "HUNT Study"]
    },
    "top_10_biobanks": {
      "total_publications": 28389,
      "percentage_of_total": 73.6
    },
    "interpretation": "Publication output is highly concentrated - top 5 biobanks produce 65% of all publications, with UK Biobank alone contributing over a third"
  },
  "eas_distribution_analysis": {
    "with_ukb": {
      "percentile_25": 10.8,
      "percentile_50": 19.7,
      "percentile_75": 35.1,
      "percentile_90": 43.1,
      "percentile_95": 48.1,
      "max": 84.6
    },
    "without_ukb": {
      "percentile_25": 10.6,
      "percentile_50": 19.5,
      "percentile_75": 34.7,
      "percentile_90": 42.7,
      "percentile_95": 45.2,
      "max": 55.2
    },
    "interpretation": "Excluding UKB minimally affects the distribution below the 95th percentile, confirming UKB is an exceptional outlier rather than distorting the overall picture"
  },
  "disease_coverage_analysis": {
    "ukb_unique_diseases": 1,
    "diseases_only_covered_by_ukb": ["Food-borne trematodiases"],
    "diseases_well_covered_only_due_to_ukb": [
      {
        "disease": "Migraine",
        "ukb_pubs": 587,
        "non_ukb_pubs": 142
      },
      {
        "disease": "Age-related macular degeneration",
        "ukb_pubs": 312,
        "non_ukb_pubs": 89
      },
      {
        "disease": "Gallbladder and biliary diseases",
        "ukb_pubs": 245,
        "non_ukb_pubs": 67
      }
    ]
  },
  "regional_impact": {
    "europe_with_ukb": {
      "biobanks": 25,
      "publications": 21482,
      "ukb_share_of_europe": 64.2
    },
    "europe_without_ukb": {
      "biobanks": 24,
      "publications": 7697,
      "notes": "Removing UKB reduces European publications by nearly two-thirds"
    }
  },
  "interpretation_guidance": [
    "UK Biobank's exceptional performance reflects its design, funding, and infrastructure - it sets a benchmark rather than distorting analysis",
    "The 'High' EAS category effectively represents UK Biobank-level achievement, which may be unrealistic for newer or lower-resourced biobanks",
    "For policy purposes, comparing biobanks to the 'Moderate' threshold (40-69) may be more actionable than to UK Biobank",
    "The analysis reveals that even well-established biobanks (NHS, WHI) have substantial equity gaps to address"
  ],
  "methodology": {
    "calculations": "Statistics computed by including/excluding UK Biobank from the 70-biobank IHCC dataset",
    "data_source": "HEIM-Biobank analysis pipeline, January 2026"
  }
}
